Literature DB >> 9260984

Angiotensin II regulates vascular smooth muscle cell pH, contraction, and growth via tyrosine kinase-dependent signaling pathways.

R M Touyz1, E L Schiffrin.   

Abstract

Angiotensin II (Ang II), a potent vasoactive peptide with mitogenic potential, influences vascular smooth muscle cell contraction and growth through receptor-linked pathways that increase intracellular free Ca2+ concentration ([Ca2+]i) and pH (pHi). Activation of these second messengers by Ang II may involve tyrosine kinase-dependent signaling pathways. This study determined the role of tyrosine kinases in Ang II-stimulated pHi, and in simultaneously measured contractile and [Ca2+]i responses, as well as growth in cultured vascular smooth muscle cells from mesenteric arteries of Wistar-Kyoto rats. pHi was determined by fluorescent digital imaging using 2',7'-bis(2-carboxyethyl)-5(6)-carboxyfluorescein acetoxymethyl ester (BCECF-AM). Vascular smooth muscle cell [Ca2+]i and contractile responses were assessed simultaneously by fura 2 methodology and by photomicroscopy in cells grown on rat tail collagen gels. Cell growth was determined by DNA and protein synthesis as measured by [3H]thymidine and [3H]leucine incorporation, respectively. The Ang II receptor subtypes (AT1 or AT2) through which Ang II mediates effects were assessed with [Sar1,Ile8]Ang II (a nonselective subtype antagonist), losartan (a selective AT1 antagonist), and PD 123319 (a selective AT2 antagonist). To determine whether tyrosine kinases influence Ang II-stimulated responses, cells were pretreated with 10(-5) mol/L tyrphostin A-23 (a specific tyrosine kinase inhibitor). Ang II increased pHi in a dose-dependent manner (pD2, 9.2+/-0.2) and significantly increased vascular smooth muscle cell contraction (30%) and [Ca2+]i (pD2, 7.4+/-0.1). Ang II (10(-7) mol/L) increased DNA ([3H]thymidine incorporation) and protein synthesis ([3H]leucine incorporation). [Sar1,Ile8]Ang II and losartan but not PD 123319 abolished Ang II-elicited responses. Tyrphostin A-23 significantly attenuated Ang II-stimulated pHi responses; it also inhibited [Ca2+]i and contractile responses and cell growth. The inactive analogue tyrphostin A-1 did not alter Ang II-stimulated actions. These results provide novel evidence for a role of tyrosine kinases in Ang II-mediated pHi responses in vascular smooth muscle cells and indicate that tyrosine kinases participate in the regulation of signal transduction associated with AT1 receptor subtype-mediated contraction and growth.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9260984     DOI: 10.1161/01.hyp.30.2.222

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  8 in total

Review 1.  A reappraisal of loop diuretic choice in heart failure patients.

Authors:  Jonathan Buggey; Robert J Mentz; Bertram Pitt; Eric L Eisenstein; Kevin J Anstrom; Eric J Velazquez; Christopher M O'Connor
Journal:  Am Heart J       Date:  2015-01-06       Impact factor: 4.749

2.  Tyrosine kinase involvement in renal arteriolar constrictor responses to angiotensin II.

Authors:  P K Carmines; R W Fallet; Q Che; K Fujiwara
Journal:  Hypertension       Date:  2001-02       Impact factor: 10.190

3.  Src family kinase involvement in rat preglomerular microvascular contractile and [Ca2+]i responses to ANG II.

Authors:  Qi Che; Pamela K Carmines
Journal:  Am J Physiol Renal Physiol       Date:  2004-11-30

4.  The angiotensin II type 1 receptor (AT1R) closely interacts with large conductance voltage- and Ca2+-activated K+ (BK) channels and inhibits their activity independent of G-protein activation.

Authors:  Zhu Zhang; Min Li; Rong Lu; Abderrahmane Alioua; Enrico Stefani; Ligia Toro
Journal:  J Biol Chem       Date:  2014-07-28       Impact factor: 5.157

5.  Secondary pulmonary hypertension: haemodynamic effects of torasemide versus furosemide.

Authors:  Vera von Dossow; Claudia Spies; Hannes Schenk; Sabine Schlesinger; Christian von Heymann
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

Review 6.  Type 2 Diabetes: Endothelial dysfunction and Exercise.

Authors:  Moon-Hyon Hwang; Sangho Kim
Journal:  J Exerc Nutrition Biochem       Date:  2014-09-26

7.  Angiotensin II, a unique vasoactive agent dissociates myosin light chain phosphorylation from contraction.

Authors:  Takashi Hirano; Takeharu Kaneda; Hiroshi Ozaki; Masatoshi Hori
Journal:  J Vet Med Sci       Date:  2017-12-20       Impact factor: 1.267

Review 8.  Aortic "Disease-in-a-Dish": Mechanistic Insights and Drug Development Using iPSC-Based Disease Modeling.

Authors:  Hongorzul Davaapil; Deeti K Shetty; Sanjay Sinha
Journal:  Front Cell Dev Biol       Date:  2020-10-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.